Differential prognostic factors in low‐ and high‐burden de novo metastatic hormone‐sensitive prostate cancer patients-Reference-Cited by-同舟云学术

Differential prognostic factors in low‐ and high‐burden de novo metastatic hormone‐sensitive prostate cancer patients

Published:2021-02-13 Issue:4 Volume:112 Page:1524-1533
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Shiota Masaki¹^ORCID,Terada Naoki²,Saito Toshihiro³,Yokomizo Akira⁴,Kohei Naoki⁵,Goto Takayuki⁶,Kawamura Sadafumi⁷,Hashimoto Yasuhiro⁸,Takahashi Atsushi⁹,Kimura Takahiro¹⁰,Tabata Ken‐ichi¹¹,Tomida Ryotaro¹²,Hashimoto Kohei¹³,Sakurai Toshihiko¹⁴,Shimazui Toru¹⁵,Sakamoto Shinichi¹⁶^ORCID,Kamiyama Manabu¹⁷,Tanaka Nobumichi¹⁸,Mitsuzuka Koji¹⁹,Kato Takuma²⁰,Narita Shintaro²¹,Yasumoto Hiroaki²²,Teraoka Shogo²³,Kato Masashi²⁴,Osawa Takahiro²⁵^ORCID,Nagumo Yoshiyuki²⁶,Matsumoto Hiroaki²⁷^ORCID,Enokida Hideki²⁸^ORCID,Sugiyama Takayuki²⁹,Kuroiwa Kentaro³⁰,Inoue Takahiro⁶,Mizowaki Takashi³¹,Kamoto Toshiyuki²,Kojima Takahiro²⁶,Kitamura Hiroshi³²,Sugimoto Mikio²⁰,Nishiyama Hiroyuki²⁶,Eto Masatoshi¹,

Affiliation:

1. Department of Urology Kyushu University Fukuoka Japan

2. Department of Urology Miyazaki University Miyazaki Japan

3. Department of Urology Niigata Cancer Center Hospital Niigata Japan

4. Department of Urology Harasanshin Hospital Fukuoka Japan

5. Department of Urology Shizuoka General Hospital Shizuoka Japan

6. Department of Urology Kyoto University Kyoto Japan

7. Department of Urology Miyagi Cancer Center Natori Japan

8. Department of Urology Hirosaki University Hirosaki Japan

9. Department of Urology Hakodate Goryoukaku Hospital Hakodate Japan

10. Department of Urology Jikei University Tokyo Japan

11. Department of Urology Kitasato University Sagamihara Japan

12. Department of Urology Shikoku Cancer Center Matsuyama Japan

13. Department of Urology Sapporo Medical University Sapporo Japan

14. Department of Urology Yamagata University Yamagata Japan

15. Department of Urology Ibaraki Prefectural Central HospitalIbaraki Cancer Center Kasama Japan

16. Department of Urology Chiba University Chiba Japan

17. Department of Urology University of Yamanashi Hospital Chuo Japan

18. Department of Urology Nara Medical University Kashihara Japan

19. Department of Urology Tohoku University Sendai Japan

20. Department of Urology Kagawa University Kagawa Japan

21. Department of Urology Akita University Akita Japan

22. Department of Urology Shimane University Izumo Japan

23. Department of Urology Tottori University Yonago Japan

24. Department of Urology Nagoya University Nagoya Japan

25. Department of Renal and Genitourinary Surgery Hokkaido University Sapporo Japan

26. Department of Urology University of Tsukuba Hospital Tsukuba Japan

27. Department of Urology Yamaguchi University Ube Japan

28. Department of Urology Kagoshima University Kagoshima Japan

29. Department of Urology Hamamatsu University School of Medicine Hamamatsu Japan

30. Department of Urology Miyazaki Prefectural Miyazaki Hospital Miyazaki Japan

31. Department of Radiation Oncology & Image‐Applied Therapy Kyoto University Kyoto Japan

32. Department of Urology Graduate School of Medicine and Pharmaceutical Sciences for Research University of Toyama Toyama Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14722

Reference23 articles.

1. Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer

2. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

3. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

4. Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

5. Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment trends in patients with de novo metastatic prostate cancer in the era of upfront combination therapy;International Journal of Urology;2024-08-23

2. Clinical efficacy of current treatments for high-volume metastatic hormone-sensitive prostate cancer: a systematic review and network meta-analysis;Holistic Integrative Oncology;2024-07-22

3. Epidemiology, treatment patterns, and clinical outcomes in de novo oligometastatic hormone‐sensitive prostate cancer;Cancer;2024-07

4. Is There an Opportunity to De-Escalate Treatments in Selected Patients with Metastatic Hormone-Sensitive Prostate Cancer?;Cancers;2024-06-26

5. Remission Depth in Metastatic Hormone-Sensitive Prostate Cancer Is Associated With Prognosis in Patients With Initial Prostate-Specific Antigen Values Above 100 Ng/ML;Cureus;2024-02-11